Associate Director, Translational Biology

Cambridge
2 weeks ago
Create job alert

CK Group are working in partnership with Nxera Pharma UK Limited (formerly Sosei Heptares), to recruit an Associate Director, to join their Translational Biology Immunology and Metabolism group.

Company:

Nxera Pharma is a technology powered biopharma company, in pursuit of new specialty medicines, to improve the lives of patients with unmet needs in Japan and globally, focused on therapeutic areas in inflammation diseases, neurology and immunology. 

Location:

Granta Park, Cambridge (UK).

The Role:

The Translational Biology Team is a multidisciplinary team, focused on understanding the mechanisms underlying human disease biology. The ideal candidate will be passionate about advancing novel therapies and biomarker strategies for the treatment of metabolic diseases, and have a proven track record of project leadership, CRO management and expertise in planning and executing preclinical target validation, and translational studies to support project deliverables.

The role will include the following responsibilities:

Scientific Project leadership; designing and executing work packages to support progression of pre-clinical Targets ensuring a robust translational framework is embedded early to drive clear decision making into the clinic.
Setting and managing budgets, communicating risks and progress to key stakeholders.
Identification of New Targets to support portfolio progression. 
Your Background:

PhD with demonstrable drug discovery background and equivalent industry experience.
Deep understanding of molecular and cellular mechanisms in obesity.
Strong proven technical knowledge for example:
in primary cell cultures/ex vivo assays (e.g. adipocyte, skeletal muscle, pancreatic islets, hepatocytes,) & relevant mechanistic endpoints (metabolic flux, lipid and glucose uptake, islet insulin release).
in vivo models of obesity (such as the DIO model) and/or of metabolic complications.
Project leadership experience within a biotech or pharma setting.
Background in translational research and proven ability to plan and execute translational strategies to support decision making in clinical studies.
Hands-on experience in managing outsourced studies with CROs or academic partners.
Good understanding of Home Office legislation governing in vivo research and direct experience in the experimental design and oversight of in vivo studies.
Excellent organisational and data management skills. 
Fantastic benefits on offer including:

State-of-the-art R&D centre located in the heart of the Cambridge science cluster.
Competitive compensation package including discretionary cash bonuses.
25 days annual leave in addition to public holidays.
Employer contribution to pension.
Private Medical Insurance and a cash plan for dental and optical reimbursement.
Health and wellbeing benefits including a subsidised individual gym membership.
Income protection to cover long term absences due to ill health.
Group Death in Service equal to 4x basic annual salary.
Apply:

It is essential that applicants hold entitlement to work in the UK. Please quote job reference (Apply online only) in all correspondence.

If this position isn't suitable but you are looking for a new role, or if you are interested in seeing what opportunities are out there, head over to our LinkedIn page (cka-group) and follow us to see our latest jobs and company news

Related Jobs

View all jobs

Associate Director, Translational Biology

Associate Director, Regulatory Affairs

Associate Director

Associate Director of Pharmacovigilance

Associate Director

Associate Director - Supply Chain Lead

Get the latest insights and jobs direct. Sign up for our newsletter.

By subscribing you agree to our privacy policy and terms of service.

Industry Insights

Discover insightful articles, industry insights, expert tips, and curated resources.

Contract vs Permanent Biotech Jobs: Which Pays Better in 2025?

In the ever-advancing world of life sciences, biotechnology has emerged as one of the fastest-growing and most impactful sectors in the UK. From gene editing and regenerative medicine to synthetic biology and vaccine development, British biotech organisations are at the forefront of scientific innovation. With this growth comes a high demand for skilled professionals—scientists, data analysts, regulatory affairs specialists, bioprocess engineers, and more—who can help bring cutting-edge treatments and products to market. However, as the biotechnology landscape in the UK continues to expand, so too do the ways in which professionals choose to work. Beyond traditional permanent employment, many biotech specialists are exploring the world of contracting, which can take the form of day‑rate consulting or fixed-term contracts (FTC). Each path promises unique advantages and disadvantages, from pay rates and benefits packages to career development and job security. This article offers a comprehensive guide on contract vs. permanent biotech jobs in 2025. We will explore how the UK biotech sector is shaping up, break down the different types of employment arrangements, and present sample take‑home pay scenarios for each. Our goal is to empower you with the knowledge needed to make an informed decision that aligns with both your financial aspirations and long-term career goals within the vibrant and evolving biotech industry.

Biotech Jobs for Non‑Technical Professionals: Where Do You Fit In?

Your Place in Britain’s Biotech Boom When most people picture biotechnology careers they imagine pipettes, petri dishes and white‑coated scientists in Cambridge or Oxford. Yet for every bench scientist there is an ecosystem of professionals who never set foot in the lab but are crucial to getting a therapy, diagnostic or food‑tech breakthrough to market. The UK BioIndustry Association (BIA) reports that non‑scientific vacancies now make up more than one‑third of all biotech job ads, and demand is accelerating. According to Vacancysoft’s Life Sciences Labour Market Trends (November 2024), biotech job postings in the Golden Triangle jumped 26 % year‑on‑year, with hotspots also emerging in Birmingham and Glasgow. Finance is following suit: the sector attracted £3.5 billion in investment during 2024, a 94 % rebound from 2023 levels. More capital means more hires in project management, regulatory affairs, and commercial operations. In short, biotech is not just for PhDs, and you don’t need to master CRISPR to make an impact. This guide explains the high‑growth, non‑technical roles; the transferable skills you already possess; real‑life transition stories; and a step‑by‑step plan to pivot into the UK’s most exciting industry.

Johnson & Johnson Biotech Jobs in 2025: Your Complete UK Guide to Joining the World’s Largest Healthcare Innovator

From the first mass‑produced sterile surgical dressings in the 1880s to first‑in‑class CAR‑T cell therapies in the 2020s, Johnson & Johnson (J&J) has continuously re‑invented healthcare. Following the 2024 spin‑off of its consumer division (Kenvue) and the rebrand of Janssen to Johnson & Johnson Innovative Medicine, the company now focuses squarely on pharmaceutical innovation, med‑tech and vision care. With revenues exceeding US $90 bn and a pipeline spanning oncology, immunology, vaccines and digital surgery, J&J remains a magnet for biotech talent. A quick scan of the Johnson & Johnson careers portal shows over 2,000 open roles in EMEA, with nearly 300 in the UK, across R&D, manufacturing, clinical affairs and data science. This guide explains how to land a Johnson & Johnson biotech job in 2025—from graduate scientist to principal data engineer.